NASDAQ:CHNG - Nasdaq - US15912K1007 - Common Stock - Currency: USD
We assign a fundamental rating of 2 out of 10 to CHNG. CHNG was compared to 36 industry peers in the Health Care Technology industry. CHNG may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CHNG is valued expensive at the moment.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.8% | ||
ROE | N/A | ||
ROIC | 1.09% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 3.43% | ||
PM (TTM) | -2.2% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.36 | ||
Debt/FCF | N/A | ||
Altman-Z | 1.12 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.23 | ||
Quick Ratio | 1.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.57 | ||
Fwd PE | 15.89 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 16.58 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
27.49
+0.07 (+0.26%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.57 | ||
Fwd PE | 15.89 | ||
P/S | 2.58 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 2.74 | ||
P/tB | N/A | ||
EV/EBITDA | 16.58 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.8% | ||
ROE | N/A | ||
ROCE | N/A | ||
ROIC | 1.09% | ||
ROICexc | N/A | ||
ROICexgc | 9.33% | ||
OM | 3.43% | ||
PM (TTM) | -2.2% | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.36 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.23 | ||
Quick Ratio | 1.23 | ||
Altman-Z | 1.12 |